Fig. 1From: Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver diseaseBoxplots of the associations between thyroid hormone levels (T4, FT4, TSH) and both MAFLD and hepatic fibrosis (using a non-invasive hepatic fibrosis scoring system). A 19,946 participants. B 5,495 patients with MAFLD. FIB-4 Fibrosis-4 index; FLD Fatty liver disease; NFS Non-alcoholic fatty hepatic fibrosis score; TSH Thyroid-stimulating hormone; T4 Thyroxine. FT4 Free thyroxineBack to article page